They found that SeNPs could inhibit PCa growth by reducing IKK-ɛ and SMAD2 mRNA levels in xenograft mice, suggesting that SeNPs could be used for anti-tumor purposes. Here, SMAD2 is linked to posterior cortical atrophy.